Trump Drug Pricing Deals.Html
The New York Times3 hrs
Pharma Companies Agree to Cut U.S. Drug Prices in Trump Deal
Is Trump's pharma deal a historic win for patients, or just empty promises that won't help most Americans?
Above: President Donald Trump enters the White House Roosevelt room in Washington, D.C., on Dec. 19, 2025. Image credit: Will Oliver/Bloomberg/Getty Images
The Spin
Pro-Trump narrative
Nine pharmaceutical giants just surrendered to Trump's demands — slashing drug prices to match the lowest in the world and ending decades of Americans subsidizing foreign health care. This represents the greatest victory for patient affordability in American health care history, with massive reductions like diabetes medication dropping from $525 to $55 and asthma inhalers falling from $265 to $89.
Anti-Trump narrative
The pharmaceutical deals are largely inconsequential to drugmakers' profit margins and won't translate into meaningful discounts for most Americans, who rely on insurance rather than cash payments. Details remain scarce on implementation, while Trump's tariff policies have greatly stressed the economy — contributing to rising prices and social anxiety.